| | | 58405 | | 25.02.2009 | | Indivior Schweiz AG | | | | | | | | | | | | | 01.01.30. | | 19.11.2025 | | 01.01.30. | | FI |
| | Seq.-Nr. | Präparat | Beschreibung | Galenische Form | ATC-Klassierung | |
|---|
| 01 | Suboxone 2 mg/0.5 mg | Sublingualtabletten | Sublingualtabletten (Buprenorphinum 2 mg, Naloxonum 0.5 mg) | N07BC51 | PI | | 02 | Suboxone 8 mg/2 mg | Sublingualtabletten | Sublingualtabletten (Buprenorphinum 8 mg, Naloxonum 2 mg) | N07BC51 | PI |
|
|